Bays, Harold E <br/><br/>
Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol.  [electronic resource] 

 -  The American journal of cardiology  Sep 2003 
 - 538-43 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9149(03)00721-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Analysis of Variance<br/>Anticholesteremic Agents--administration & dosage<br/>Apolipoprotein A-I--blood<br/>Apolipoprotein A-II--blood<br/>Apolipoproteins B--blood<br/>Apolipoproteins C--blood<br/>Apolipoproteins E--blood<br/>Caproates--administration & dosage<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Hypercholesterolemia--blood<br/>Hypertriglyceridemia--blood<br/>Male<br/>Middle Aged<br/>Treatment Outcome<br/>Triglycerides--blood